Key takeaways Nausea is the most common side effect of Wegovy, Zepbound, Ozempic, Mounjaro, and Foundayo, and the most common reason patients in trials and in clinic consider stopping
Yes, Because: Actual costs support this pricing Efficient telehealth model works Scale allows low margins to work Competition prevents price increases Patient demand strong Market Will Stabilize Around: Low-end: $329-$399/month (efficient operators) Mid-range: $400-$549/month (typical providers) High-end: $550-$699/month (premium services) Prices unlikely to go below $300/month: Costs dont support lower pricing Medical oversight required Quality cant be compromised Current pricing is sustainable and will persist
10.1016/S0014-2999(00)00600-2 30
The convenience and cost can be appealing, but there are some risks
Potential Side Effects and Safety Considerations When considering B12 injections alongside Mounjaro, it is important to understand the side effect profile of each treatment independently, as well as practical safety considerations